Correspondence on 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement'

被引：5
作者：
Banday, Aaqib Zaffar [1 ]
Jindal, Ankur Kumar [1 ]
Singh, Surjit [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Dept Pediat, Allergy Immunol Unit, Chandigarh, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷 / 05期
关键词：
autoimmunity; immune system diseases; inflammation; therapeutics; RUXOLITINIB; EFFICACY;
D O I：
10.1136/annrheumdis-2021-219890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[31]   Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases [J].
Patterson, H. ;
Nibbs, R. ;
McInnes, I. ;
Siebert, S. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (01) :1-10
[32]   Use of external control arms in immune-mediated inflammatory diseases: a systematic review [J].
Zayadi, Alexa ;
Edge, Robert ;
Parker, Claire E. ;
Macdonald, John K. ;
Neustifter, Blue ;
Chang, Joshua ;
Zhong, Guowei ;
Singh, Siddharth ;
Feagan, Brian G. ;
Ma, Christopher ;
Jairath, Vipul .
BMJ OPEN, 2023, 13 (12)
[33]   COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases [J].
Serra Lopez-Matencio, Jose M. ;
Vicente-Rabaneda, Esther F. ;
Alanon, Estefania ;
Aranguren Oyarzabal, Ainhoa ;
Martinez Fleta, Pedro ;
Castaneda, Santos ;
Maggi, Fabrizio ;
Bordi, Licia .
VACCINES, 2023, 11 (12)
[34]   Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis [J].
Andersen, Yuki M. F. ;
Wu, Jashin J. ;
Thyssen, Jacob P. ;
Egeberg, Alexander .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (06) :1283-1291
[35]   Use of coronarycomputed tomography for cardiovascular risk assessment in immune-mediated inflammatory diseases [J].
Peverelli, Marta ;
Maughan, Robert T. ;
Gopalan, Deepa ;
Dweck, Marc R. ;
Dey, Damini ;
Buch, Maya H. ;
Rudd, James H. F. ;
Tarkin, Jason M. .
HEART, 2024, 110 (08) :545-551
[36]   Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases [J].
Borchers, Andrea T. ;
Leibushor, Naama ;
Cheema, Gurtej S. ;
Naguwa, Stanley M. ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2011, 37 (04) :273-288
[37]   Protein-kinase inhibitors: A new treatment pathway for autoimmune and inflammatory diseases? [J].
Hernandez-Florez, Diana ;
Valor, Lara .
REUMATOLOGIA CLINICA, 2016, 12 (02) :91-99
[38]   Sphingosine 1-phosphate receptor modulators for the treatment of inflammatory bowel disease and other immune-mediated diseases [J].
Xu, Lifan ;
Lu, Peng ;
Wang, Yubin .
MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (12) :2074-2088
[39]   Risk of serious infection with JAK inhibitors in immune-mediated inflammatory skin diseases: a meta-analysis of randomized clinical trials [J].
Su, Xinhong ;
Ou, Yushan ;
Ruan, Shifan ;
Lv, Xiaoqing ;
Qin, Kun ;
Mao, Jing ;
Ji, Chao .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
[40]   Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases A Systematic Review and Meta-Analysis [J].
Ingrassia, Jenne P. ;
Maqsood, Muhammad Haisum ;
Gelfand, Joel M. ;
Weber, Brittany N. ;
Bangalore, Sripal ;
Lo Sicco, Kristen I. ;
Garshick, Michael S. .
JAMA DERMATOLOGY, 2024, 160 (01) :28-36
12345